digital therapy can be used alone or in conjunction with other therapies. Among them, wearable devices are increasingly used in conjunction with digital therapies. For example, Apple Company through Apple Watch and its accessories have obtained three FDA medical device certificates in recent years. Among many wearable devices, VR technology is widely used, such as surgical teaching, surgical navigation and cognitive behavioral therapy.
Currently, wearable devices + VR technology are widely used in digital therapy. The reasons are: first, VR technology is the most mature in consumer entertainment, which is consistent with the current stage of digital therapy mostly in the form of specially designed games; at the same time, VR solutions are relatively mature, including HTC, Oculus, Sony and Pico and other major VR equipment manufacturers can provide relatively complete technical support and integration services, and the integration difficulty is relatively low.
JOGO Health is a digital therapy company that specializes in using wearable sensing technology and artificial intelligence . The company has not only obtained FDA approval, but is also the founder of the world's first digital stroke clinic, digital incontinence clinic, and digital cerebral palsy clinic.
JOGO Health was founded in 2019 and is committed to the treatment of chronic pain and neuromuscular diseases using a multidisciplinary approach of rehabilitation medicine, mobile technology, sensor technology, AI/ML, game design and behavioral science. The company has developed the JOGO family of products, which are digital therapeutic products for the treatment of neuromuscular disorders (NM) such as stroke, spinal cord injury, cerebral palsy , Bell's palsy, urinary and fecal incontinence and other NM conditions. JOGO helps enhance rewiring of the central nervous system to improve voluntary control of muscles lost due to stroke and other neuromuscular diseases. JOGO consists of a wearable wireless s/EMG sensor and a patent-protected mobile app.
JOGO's main product is JOGO-Gx, which is used to treat more than ten neuromuscular diseases, mainly cerebral palsy. According to statistics, 3 out of every 1,000 children are born with cerebral palsy. JOGO-Gx consists of an AI-powered mobile app and wearable sensors that provide virtual treatment for chronic pain and movement disorders by harnessing the brain’s neuroplasticity. After nine years of research, JOGO-Gx obtained an innovation patent from the United States Patent and Trademark Office (USPTO) in 2019; in 2020, JOGO-Gx obtained FDA Class II medical device certification.
JOGO currently focuses on diseases in four fields: cerebral palsy, stroke, pain, urology and obstetrics and gynecology diseases.
Among them, pain diseases mainly include pelvic pain, migraine / tension-type headache , and chronic low back pain. According to the study results, 9 out of 10 patients who received JOGO digital therapy-assisted pelvic floor muscle training experienced an average pain reduction of 90%. In more than 150 studies, EMG biofeedback therapy created by JOGO is more effective in treating tension-type headache than standard migraine therapy. In a study conducted at Brigham and Women's Hospital/Harvard Medical School, JOGO was shown to be very effective in treating chronic low back pain compared to a control group.
In terms of urological and obstetrical and gynecological diseases, JOGO focuses on urinary incontinence , pelvic organ prolapse and urinary dysfunction. All three types of diseases can be treated through JOGO Digital Therapy (DTx)-assisted pelvic floor muscle training (PFMT) without the side effects of drugs and surgical complications. JOGO therapy uses the clinically proven science of EMG biofeedback and consists of eight 45-minute sessions over an eight-week period. The American Urological Association (AUA) and the American Society of Urogynecologists (AUGS) recommend JOGO biofeedback-assisted pelvic floor muscle training (PFMT) as first-line treatment for urinary incontinence, pelvic organ prolapse, and voiding dysfunction before trying medications or surgery.
According to statistics, one in three women and one in ten men suffers from mild urinary incontinence or complete inability to control urination after sneezing, coughing or laughing. Nine out of 10 patients who received JOGO digital therapy-assisted pelvic floor muscle training treatment avoided surgery and stopped taking medications, and the average patient improvement was as high as 90%.
Pelvic organ prolapse (POP) affects 346 million women worldwide (9.3% of all women).Pelvic organ prolapse occurs when the muscles and tissues that support the pelvic organs (uterus, bladder, or rectum) become weak or loose. In a recent study, 9 out of 10 POP patients treated with JOGO successfully avoided surgery.
Urinary dysfunction is when there is inconsistent urinary coordination between the bladder muscles and the urethra, which results in the pelvic floor muscles not fully relaxing or being overactive during urination. Urinary dysfunction is estimated to be present in more than half of the elderly population. Patients with urinary dysfunction who received JOGO digital therapy-assisted pelvic floor muscle training experienced an average improvement of 80% and avoided surgery.
JOGO Health product pipeline
JOGO Health co-founder Siva Nadarajah, has more than 23 years of experience in the pharmaceutical industry; co-founder SANJAI MURALI, has more than 20 years of experience in developing and marketing technology solutions.
(Author of this article: Zhang Qingxia; Editor: Fan Xiaoxin)
